Gambling, Resorts & Casinos
Build Your Comparison
Side-by-side financial analysisStock Comparison
ROLR vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
Internet Content & Information
ROLR vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Gambling, Resorts & Casinos | Internet Content & Information |
| Market Cap | $57M | $1.76B |
| Revenue (TTM) | $17M | $713M |
| Net Income (TTM) | $1M | $-159M |
| Gross Margin | 49.6% | 22.6% |
| Operating Margin | -34.5% | -18.3% |
| Forward P/E | 17.6x | — |
| Total Debt | $807K | $30M |
| Cash & Equiv. | $2M | $281M |
ROLR vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | Jun 26 | Return |
|---|---|---|---|
| High Roller Technol… (ROLR) | 100 | Infinity | +Infinity% |
| Genius Sports Limit… (GENI) | 100 | 89.9 | -10.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ROLR vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ROLR carries the broadest edge in this set and is the clearest fit for quality and momentum.
- 5.9% margin vs GENI's -22.3%
- +137.8% vs GENI's -34.6%
- 4.6% ROA vs GENI's -15.4%, ROIC -119.9% vs -16.6%
GENI is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.59
- Rev growth 31.0%, EPS growth -63.0%, 3Y rev CAGR 25.2%
- Lower volatility, beta 1.59, Low D/E 4.2%, current ratio 1.56x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.0% revenue growth vs ROLR's -26.6% | |
| Quality / Margins | 5.9% margin vs GENI's -22.3% | |
| Stability / Safety | Beta 1.59 vs ROLR's 2.73, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +137.8% vs GENI's -34.6% | |
| Efficiency (ROA) | 4.6% ROA vs GENI's -15.4%, ROIC -119.9% vs -16.6% |
ROLR vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ROLR vs GENI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — ROLR and GENI each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GENI is the larger business by revenue, generating $713M annually — 41.8x ROLR's $17M. ROLR is the more profitable business, keeping 5.9% of every revenue dollar as net income compared to GENI's -22.3%. On growth, GENI holds the edge at +30.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $17M | $713M |
| EBITDAEarnings before interest/tax | -$6M | -$54M |
| Net IncomeAfter-tax profit | $1M | -$159M |
| Free Cash FlowCash after capex | -$3M | $16M |
| Gross MarginGross profit ÷ Revenue | +49.6% | +22.6% |
| Operating MarginEBIT ÷ Revenue | -34.5% | -18.3% |
| Net MarginNet income ÷ Revenue | +5.9% | -22.3% |
| FCF MarginFCF ÷ Revenue | -17.2% | +2.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -50.3% | +30.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +25.6% | -6.0% |
Valuation Metrics
GENI leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $57M | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $56M | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | 17.64x | -15.57x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | 0.16x | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 2.78x | 2.63x |
| Price / BookPrice ÷ Book value/share | 6.36x | 2.41x |
| Price / FCFMarket cap ÷ FCF | — | 27.33x |
Profitability & Efficiency
Evenly matched — ROLR and GENI each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
ROLR delivers a 7.9% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-22 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ROLR's 0.08x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +7.9% | -22.2% |
| ROA (TTM)Return on assets | +4.6% | -15.4% |
| ROICReturn on invested capital | -119.9% | -16.6% |
| ROCEReturn on capital employed | -63.7% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 |
| Debt / EquityFinancial leverage | 0.08x | 0.04x |
| Net DebtTotal debt minus cash | -$1M | -$250M |
| Cash & Equiv.Liquid assets | $2M | $281M |
| Total DebtShort + long-term debt | $807,000 | $30M |
| Interest CoverageEBIT ÷ Interest expense | -17.49x | -75.96x |
Total Returns (Dividends Reinvested)
ROLR leads this category, winning 2 of 2 comparable metrics.
Total Returns (Dividends Reinvested)
Over the past 12 months, ROLR leads with a +137.8% total return vs GENI's -34.6%.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +190.0% | -36.5% |
| 1-Year ReturnPast 12 months | +137.8% | -34.6% |
| 3-Year ReturnCumulative with dividends | — | +13.4% |
| 5-Year ReturnCumulative with dividends | — | -62.2% |
| 10-Year ReturnCumulative with dividends | — | -31.5% |
| CAGR (3Y)Annualised 3-year return | — | +4.3% |
Risk & Volatility
GENI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GENI is the less volatile stock with a 1.59 beta — it tends to amplify market swings less than ROLR's 2.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GENI currently trades 49.9% from its 52-week high vs ROLR's 18.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.73x | 1.59x |
| 52-Week HighHighest price in past year | $33.68 | $13.73 |
| 52-Week LowLowest price in past year | $1.16 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +18.9% | +49.9% |
| RSI (14)Momentum oscillator 0–100 | 60.9 | 73.2 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 5.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $9.40 |
| # AnalystsCovering analysts | — | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
GENI leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). ROLR leads in 1 (Total Returns). 2 tied.
ROLR vs GENI: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is ROLR or GENI a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus -26. 6% for High Roller Technologies, Inc. (ROLR). High Roller Technologies, Inc. (ROLR) offers the better valuation at 17. 6x trailing P/E, making it the more compelling value choice. Analysts rate Genius Sports Limited (GENI) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is safer — ROLR or GENI?
By beta (market sensitivity over 5 years), Genius Sports Limited (GENI) is the lower-risk stock at 1.
59β versus High Roller Technologies, Inc. 's 2. 73β — meaning ROLR is approximately 72% more volatile than GENI relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 8% for High Roller Technologies, Inc. — giving it more financial flexibility in a downturn.
03Which is growing faster — ROLR or GENI?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus -26. 6% for High Roller Technologies, Inc. (ROLR). On earnings-per-share growth, the picture is similar: High Roller Technologies, Inc. grew EPS 143. 9% year-over-year, compared to -63. 0% for Genius Sports Limited. Over a 3-year CAGR, GENI leads at 25. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — ROLR or GENI?
High Roller Technologies, Inc.
(ROLR) is the more profitable company, earning 3. 4% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 3. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GENI leads at -15. 6% versus -27. 8% for ROLR. At the gross margin level — before operating expenses — ROLR leads at 53. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — ROLR or GENI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is ROLR or GENI better for a retirement portfolio?
For long-horizon retirement investors, Genius Sports Limited (GENI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
High Roller Technologies, Inc. (ROLR) carries a higher beta of 2. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between ROLR and GENI?
These companies operate in different sectors (ROLR (Consumer Cyclical) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ROLR is a small-cap deep-value stock; GENI is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.
Compare GENI vs SRAD
SRAD is one of the most direct listed alternatives to GENI.
Compare ROLR vs DKNG
DKNG overlaps with ROLR in an adjacent operating segment worth comparing.
Expand With SRAD + DKNG
SRAD and DKNG are the strongest missing peers across the current compare set.